Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

Mechanisms of Diabetic Complications

(2013) Josephine M. Forbes et al.   PHYSIOLOGICAL REVIEWS

The worldwide diabetes epidemic

(2013) David W. Lam et al.   Current Opinion in Endocrinology Diabetes and Obesity

High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

(2012) M. M. Poulsen et al.   DIABETES

Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study

(2012) H. Sone et al.   DIABETES CARE

Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control

(2012) J. A. Hirst et al.   DIABETES CARE

Type 2 Diabetes: An Epidemic Requiring Global Attention and Urgent Action

(2012) W. H. Herman et al.   DIABETES CARE

Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance

(2012) Jill P. Crandall et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets indb/dbmice

(2012) Gyeong-Min Do et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

(2012) Jayesh Kumar Bhatt et al.   NUTRITION RESEARCH

Anti-diabetic effects of resveratrol

(2011) Tomasz Szkudelski et al.   Annals of the New York Academy of Sciences

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

(2011) Pál Brasnyó et al.   BRITISH JOURNAL OF NUTRITION

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway

(2011) Sijo J. Thandapilly et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cellular and molecular effects of resveratrol in health and disease

(2011) Wei Yu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age

(2011) Simonetta Genovesi et al.   JOURNAL OF HYPERTENSION

Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats

(2011) Xavier L. Louis et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Resveratrol and health - A comprehensive review of human clinical trials

(2011) James M. Smoliga et al.   MOLECULAR NUTRITION & FOOD RESEARCH

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

(2011) Ole Vang et al.   PLoS One

Glycemic Control and Complications in Type 2 Diabetes Mellitus

(2010) Mark Stolar   AMERICAN JOURNAL OF MEDICINE

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

(2010) V. A. Brown et al.   CANCER RESEARCH

Resveratrol: A Multifunctional Cytoprotective Molecule

(2010) Bela Juhasz et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes

(2010) Sameer Sharma et al.   PHYTOTHERAPY RESEARCH

Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure

(2009) S. J. Thandapilly et al.   AMERICAN JOURNAL OF HYPERTENSION

Central Administration of Resveratrol Improves Diet-Induced Diabetes

(2009) Giorgio Ramadori et al.   ENDOCRINOLOGY

Current views on type 2 diabetes

(2009) Yi Lin et al.   JOURNAL OF ENDOCRINOLOGY